BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31519555)

  • 1. Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
    Wöll E; Eisterer W; Gerger A; Kühr T; Prager GW; Rumpold H; Ulrich-Pur H; Vogl U; Winder T; Weiss L; Greil R
    Anticancer Res; 2019 Sep; 39(9):4589-4596. PubMed ID: 31519555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An Update.
    Wöll E; Amann A; Eisterer W; Gerger A; Grünberger B; Rumpold H; Weiss L; Winder T; Greil R; Prager GW
    Anticancer Res; 2023 Jul; 43(7):2889-2897. PubMed ID: 37351962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HER2 in the management of potentially resectable gastric adenocarcinoma: what are oncologists waiting for?
    Gharib KE; R Kourie H
    Future Oncol; 2020 Nov; 16(33):2683-2686. PubMed ID: 32805125
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of gastric adenocarcinoma.
    Waller MB
    Nurs Clin North Am; 2001 Sep; 36(3):543-52, xi. PubMed ID: 11532668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative management of gastric cancer.
    Cunningham SC; Schulick RD
    Surg Oncol; 2007 Dec; 16(4):267-75. PubMed ID: 17881220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.
    Rivera F; Grávalos C; García-Carbonero R;
    Clin Transl Oncol; 2012 Jul; 14(7):528-35. PubMed ID: 22721798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications.
    Sanjeevaiah A; Cheedella N; Hester C; Porembka MR
    J Oncol Pract; 2018 Apr; 14(4):217-224. PubMed ID: 29641950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastric neoplasm, multidisciplinary management].
    Bohanes Pi; Roth AD; Huber O; Aapro MS; Plan PA
    Rev Med Suisse; 2009 Aug; 5(212):1569-75. PubMed ID: 19728453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current standards in the treatment of gastric cancer].
    Hacker U; Lordick F
    Dtsch Med Wochenschr; 2015 Aug; 140(16):1202-5. PubMed ID: 26261926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seom guidelines for the treatment of gastric cancer 2015.
    Martin-Richard M; Custodio A; García-Girón C; Grávalos C; Gomez C; Jimenez-Fonseca P; Manzano JL; Pericay C; Rivera F; Carrato A
    Clin Transl Oncol; 2015 Dec; 17(12):996-1004. PubMed ID: 26691658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HER2 testing in gastric cancer : Results of a meeting of German experts].
    Baretton G; Dietel M; Gaiser T; Kirchner T; Kreipe HH; Quaas A; Röcken C; Rüschoff J; Tannapfel A; Lordick F; Al-Batran S; Hofheinz R; Lorenzen S; Moehler M; Thuss-Patience P
    Pathologe; 2016 Jul; 37(4):361-6. PubMed ID: 27376648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer. Update on diagnosis, staging, and therapy.
    Latif A
    Postgrad Med; 1997 Oct; 102(4):231-6, 241. PubMed ID: 9336609
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.
    Bang YJ
    J Clin Gastroenterol; 2012 Sep; 46(8):637-48. PubMed ID: 22751336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).
    Martín-Richard M; Carmona-Bayonas A; Custodio AB; Gallego J; Jiménez-Fonseca P; Reina JJ; Richart P; Rivera F; Alsina M; Sastre J
    Clin Transl Oncol; 2020 Feb; 22(2):236-244. PubMed ID: 31989475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment in resectable non-metastatic adenocarcinoma of stomach: Changing paradigms.
    Chelakkot PG; Ravind R; Sruthi K; Menon D
    Indian J Cancer; 2019; 56(1):74-80. PubMed ID: 30950450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER2 testing in gastric and gastroesophageal adenocarcinomas.
    Vakiani E
    Adv Anat Pathol; 2015 May; 22(3):194-201. PubMed ID: 25844677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives in adjuvant therapy of gastric cancer.
    De Vita F; Vecchione L; Galizia G; Di Martino N; Fabozzi T; Catalano G; Ciardiello F; Orditura M
    Oncology; 2009; 77 Suppl 1():38-42. PubMed ID: 20130430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer after mini-gastric bypass surgery: a case report and literature review.
    Wu CC; Lee WJ; Ser KH; Chen JC; Tsou JJ; Chen SC; Kuan WS
    Asian J Endosc Surg; 2013 Nov; 6(4):303-6. PubMed ID: 24308590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma.
    Curea FG; Hebbar M; Ilie SM; Bacinschi XE; Trifanescu OG; Botnariuc I; Anghel RM
    Cancer Biother Radiopharm; 2017 Dec; 32(10):351-363. PubMed ID: 29265917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.